| Primary |
| Product Used For Unknown Indication |
25.9% |
| Drug Use For Unknown Indication |
24.1% |
| Macular Degeneration |
15.2% |
| Age-related Macular Degeneration |
14.2% |
| Diabetic Retinal Oedema |
4.3% |
| Hypertension |
3.6% |
| Diabetes Mellitus |
1.9% |
| Choroidal Neovascularisation |
1.6% |
| Prophylaxis |
1.2% |
| Maculopathy |
1.2% |
| Macular Oedema |
1.1% |
| Retinal Vein Occlusion |
0.9% |
| Polypoidal Choroidal Vasculopathy |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Hypercholesterolaemia |
0.7% |
| Hypothyroidism |
0.7% |
| Cardiovascular Event Prophylaxis |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Blood Cholesterol Increased |
0.5% |
| Anxiety |
0.4% |
|
| Visual Acuity Reduced |
21.0% |
| Death |
19.0% |
| Retinal Haemorrhage |
7.9% |
| Myocardial Infarction |
7.6% |
| Cerebrovascular Accident |
7.2% |
| Vitreous Haemorrhage |
6.7% |
| Retinal Pigment Epithelial Tear |
6.3% |
| Visual Impairment |
3.7% |
| Cerebral Infarction |
2.9% |
| Pneumonia |
2.6% |
| Transient Ischaemic Attack |
2.6% |
| Retinal Detachment |
1.9% |
| Ocular Hypertension |
1.7% |
| Detachment Of Retinal Pigment Epithelium |
1.6% |
| Vision Blurred |
1.4% |
| Diabetes Mellitus |
1.2% |
| Hypertension |
1.2% |
| Malaise |
1.2% |
| Fall |
1.2% |
| Blindness |
1.1% |
|
| Secondary |
| Product Used For Unknown Indication |
38.1% |
| Age-related Macular Degeneration |
23.2% |
| Macular Degeneration |
12.8% |
| Drug Use For Unknown Indication |
8.8% |
| Polypoidal Choroidal Vasculopathy |
2.7% |
| Diabetic Retinal Oedema |
2.6% |
| Hypertension |
2.5% |
| Diabetes Mellitus |
1.7% |
| Choroidal Neovascularisation |
1.4% |
| Retinal Vein Occlusion |
1.4% |
| Macular Oedema |
0.9% |
| Visual Impairment |
0.7% |
| Diabetic Retinopathy |
0.5% |
| Hypercholesterolaemia |
0.5% |
| Angina Pectoris |
0.4% |
| Hyperlipidaemia |
0.4% |
| Maculopathy |
0.4% |
| Off Label Use |
0.4% |
| Prophylaxis |
0.3% |
| Cardiovascular Insufficiency |
0.3% |
|
| Visual Acuity Reduced |
26.2% |
| Death |
9.5% |
| Retinal Haemorrhage |
9.5% |
| Retinal Pigment Epithelial Tear |
8.7% |
| Inappropriate Schedule Of Drug Administration |
6.5% |
| Vitreous Haemorrhage |
6.3% |
| Cerebrovascular Accident |
5.3% |
| Myocardial Infarction |
3.6% |
| Retinal Detachment |
3.4% |
| Visual Impairment |
3.3% |
| Detachment Of Retinal Pigment Epithelium |
2.3% |
| Prostate Cancer Metastatic |
2.3% |
| Transient Ischaemic Attack |
2.1% |
| Cerebral Infarction |
2.0% |
| Pancreatic Carcinoma |
2.0% |
| Renal Failure |
1.5% |
| Intraocular Pressure Increased |
1.4% |
| Retinal Scar |
1.4% |
| Choroidal Dystrophy |
1.4% |
| Pneumonia |
1.4% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
23.0% |
| Product Used For Unknown Indication |
16.4% |
| Hypertension |
10.3% |
| Macular Oedema |
8.5% |
| Atherosclerosis Prophylaxis |
7.3% |
| Gastritis |
4.2% |
| Macular Degeneration |
4.2% |
| Blood Cholesterol |
3.6% |
| Ill-defined Disorder |
3.6% |
| Diabetes Mellitus |
3.0% |
| Antiviral Prophylaxis |
1.8% |
| Hyperthyroidism |
1.8% |
| Intraocular Pressure Increased |
1.8% |
| Retinal Disorder |
1.8% |
| Scleritis |
1.8% |
| Sleep Disorder |
1.8% |
| Age-related Macular Degeneration |
1.2% |
| Cardiac Failure Congestive |
1.2% |
| Cardiovascular Event Prophylaxis |
1.2% |
| Coronary Artery Disease |
1.2% |
|
| Colitis Microscopic |
10.7% |
| Prostatic Haemorrhage |
10.7% |
| Diarrhoea |
7.1% |
| Renal Cell Carcinoma |
7.1% |
| Retinal Vein Occlusion |
7.1% |
| Skin Irritation |
7.1% |
| Aortic Aneurysm |
3.6% |
| Cytomegalovirus Chorioretinitis |
3.6% |
| Eye Disorder |
3.6% |
| Glossodynia |
3.6% |
| Hypertensive Crisis |
3.6% |
| Intraocular Pressure Increased |
3.6% |
| Myocardial Infarction |
3.6% |
| Non-infectious Endophthalmitis |
3.6% |
| Pneumonia Aspiration |
3.6% |
| Pyrexia |
3.6% |
| Renal Artery Thrombosis |
3.6% |
| Renal Failure |
3.6% |
| Rhabdomyosarcoma |
3.6% |
| Shock Hypoglycaemic |
3.6% |
|
